Group One Trading’s Annovis Bio ANVS Stock Holding History

Group One Trading’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56K	Sell	700 -4,500	-87%	-$12.3K	﹤0.01%	7118
2025 Q4	$18K	Sell	5,200 -200	-4%	-$601	﹤0.01%	6422
2025 Q3	$11.2K	Sell	5,400 -4,900	-48%	-$12.2K	﹤0.01%	7101
2025 Q2	$22.4K	Sell	10,300 -40,700	-80%	-$80.3K	﹤0.01%	6198
2025 Q1	$76.5K	Sell	51,000 -50,000	-50%	-$153K	﹤0.01%	4822
2024 Q4	$508K	Sell	101,000 -392,900	-80%	-$2.84M	﹤0.01%	3159
2024 Q3	$3.98M	Buy	493,900 +144,200	+41%	+$1.35M	0.01%	1178
2024 Q2	$2.01M	Buy	349,700 +107,500	+44%	+$871K	0.01%	1450
2024 Q1	$2.88M	Buy	+242,200	New	+$2.64M	0.01%	1219

Other funds holding ANVS

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Group One Trading's ANVS Position: Q1 2026 in Review

Group One Trading increased its Annovis Bio (ANVS) stake by 0.78% in Q1 2026, buying an estimated $1.47K and bringing the position to 69,663 shares worth $155K. The position accounts for ﹤0.01% of the portfolio, ranked #4333.

Group One Trading first reported a position in ANVS in Q3 2024 and has held it in 7 quarters since. The position peaked at $425K in Q3 2024. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

Group One Trading held 69,663 shares of Annovis Bio worth $155K as of Q1 2026.
Group One Trading bought 537 Annovis Bio shares in Q1 2026, an estimated $1.47K.
Annovis Bio made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4333 holding.
Group One Trading first reported a position in Annovis Bio in Q3 2024 and has held it in 7 quarters since.
Group One Trading's Annovis Bio position peaked at $425K in Q3 2024.
56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.